A study of Foxy-5 in patients with metastatic breast, colon or prostate cancer

Trial Profile

A study of Foxy-5 in patients with metastatic breast, colon or prostate cancer

Planning
Phase of Trial: Phase II

Latest Information Update: 24 Mar 2017

At a glance

  • Drugs Foxy 5 (Primary)
  • Indications Breast cancer; Colon cancer; Prostate cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 24 Mar 2017 New trial record
    • 21 Mar 2017 According to a WntResearch media release, the company anticipates to commence this study later in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top